Evidence map›Paper›PMID 28652370›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of

Jolieke G van Oosterwijk, Chunliang Li, Xue Yang, Joseph T Opferman, Charles J Sherr

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Epigenetic Control ofCancer research · 2020
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jolieke G van OosterwijkHoward Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Chunliang LiDepartment of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Xue YangCell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Joseph T OpfermanCell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105.
Charles J SherrHoward Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN 38105; sherr@stjude.org.ORCID 0000-0002-5516-6206
St. Jude Children's Research Hospital · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

The mouse p19

Indexed as

3T3 CellsAnimalsBlindnessCell ProliferationCodonCyclin-Dependent Kinase Inhibitor p16DeoxyribonucleasesFemaleFibroblastsFusion Proteins, bcr-ablGenes, Tumor SuppressorGerm CellsMaleMiceMice, Inbred C57BLMitochondriaCdkn2a protein, mouseCodonCyclin-Dependent Kinase Inhibitor p16DeoxyribonucleasesFusion Proteins, bcr-ablTumor Suppressor Protein p53Arf tumor suppressorBCR-ABL acute lymphoblastic leukemiahyaloid vasculaturep53spermatogenesis

Identifiers

PMID28652370
PMCPMC5514764
OpenAlexW2657712373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.